NovoTTF-100L System, combined with chemotherapy, is FDA-approved for malignant pleural mesothelioma, marking the first new treatment in over 15 years. The STELLAR trial showed a median overall ...
Microarray ANALYSIS of t(11;18)(Q21;Q21)-positive and -negative gastrointestinal MALT lymphomas. Background: Malignant peritoneal mesothelioma (MPM) is a rare disease and prognosis is poor. The ...
Malignant pleural mesothelioma, an aggressive cancer that affects the lining of the lungs, is fatal in most cases. The majority of patients will die within a year and a half of diagnosis. The ...
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse ...
The FDA has approved the NovoTTF-100L System (Novocure) in combination with pemetrexed plus platinum-based chemotherapy for the first-line treatment of unresectable, locally advanced or metastatic, ...
RAHWAY, N.J. & KINGSTON, Ontario--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and the Canadian Cancer Trials Group (CCTG) today announced that the Phase ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved nivolumab in combination with ipilimumab for the treatment of adults with unresectable ...
Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer ...
Only modest improvements in the systemic treatment of MPM patients have been made in the last decade, after the presentation of the results of the EMPHACIS Phase III study, which led to the ...
Patients with mesothelioma may be getting a new second-line treatment, thanks to results from a recent immunotherapy trial. For patients with malignant pleural mesothelioma — which makes up about 90 ...
Photodynamic therapy with PHOTOFRIN® is a two-stage process requiring administration of both drug and light. The first stage of PDT is the intravenous injection of PHOTOFRIN®. Illumination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results